DK2029121T3 - Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel - Google Patents

Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel

Info

Publication number
DK2029121T3
DK2029121T3 DK07725656.8T DK07725656T DK2029121T3 DK 2029121 T3 DK2029121 T3 DK 2029121T3 DK 07725656 T DK07725656 T DK 07725656T DK 2029121 T3 DK2029121 T3 DK 2029121T3
Authority
DK
Denmark
Prior art keywords
active ingredient
therapeutic system
transdermal therapeutic
system containing
flow
Prior art date
Application number
DK07725656.8T
Other languages
Danish (da)
English (en)
Inventor
Tobias Jung
Michael Horstmann
Mohammad Sameti
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38520773&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2029121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK2029121T3 publication Critical patent/DK2029121T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07725656.8T 2006-06-08 2007-05-30 Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel DK2029121T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006026578A DE102006026578B4 (de) 2006-06-08 2006-06-08 Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
PCT/EP2007/004765 WO2007140909A1 (de) 2006-06-08 2007-05-30 Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss

Publications (1)

Publication Number Publication Date
DK2029121T3 true DK2029121T3 (da) 2010-06-07

Family

ID=38520773

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07725656.8T DK2029121T3 (da) 2006-06-08 2007-05-30 Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel

Country Status (13)

Country Link
US (2) US10292942B2 (https=)
EP (1) EP2029121B1 (https=)
JP (1) JP5757682B2 (https=)
CN (1) CN101466361B (https=)
AT (1) ATE459345T1 (https=)
BR (1) BRPI0712420A2 (https=)
CA (1) CA2652216C (https=)
DE (2) DE102006026578B4 (https=)
DK (1) DK2029121T3 (https=)
ES (1) ES2340732T3 (https=)
PL (1) PL2029121T3 (https=)
PT (1) PT2029121E (https=)
WO (1) WO2007140909A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US8369942B2 (en) * 2008-03-20 2013-02-05 The Invention Science Fund I, Llc Subdermal material delivery device
JP5552255B2 (ja) * 2008-04-16 2014-07-16 日東電工株式会社 薬物経皮投与デバイス
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
EA201300255A1 (ru) 2010-08-23 2013-06-28 Такеда Гмбх Увлажненные частицы, содержащие терапевтически активное вещество
DE102011090178A1 (de) * 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
AP2015008920A0 (en) 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
US10897978B2 (en) 2014-10-21 2021-01-26 The Procter & Gamble Company Method of improving skin appearance
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
WO2017070078A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
EP3365067B1 (en) 2015-10-22 2019-11-20 The Procter and Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10751265B2 (en) * 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
CN110167642B (zh) * 2017-01-09 2022-06-07 宝洁公司 具有可溶性膜的阻隔贴片和改善皮肤外观的方法
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
EP3641952B1 (en) * 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
KR102524880B1 (ko) * 2017-12-21 2023-04-21 한양대학교 산학협력단 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치
US10751266B2 (en) 2018-03-19 2020-08-25 The Procter & Gamble Company Method of making a barrier patch with soluble film
US12491166B2 (en) 2020-08-31 2025-12-09 Wacker Chemie Ag Method of delivering an active compound and delivery device for use in the same
US12201733B2 (en) * 2021-03-08 2025-01-21 Nikita Patel Transdermal delivery system

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3965482A (en) * 1974-11-12 1976-06-22 Rca Corporation Velocity correction circuit for video discs
US4460372A (en) 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
GB8629640D0 (en) 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US5059189A (en) 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
IT1230566B (it) 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US6238700B1 (en) 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
ATE204787T1 (de) * 1997-10-06 2001-09-15 Adalbert Raps Stiftung Verfahren zur herstellung eines pulverförmigen produktes aus einem flüssigen stoff oder stoffgemisch
DE19844079A1 (de) * 1998-05-22 1999-11-25 Novosis Pharma Ag Biphasische Transdermalsysteme
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung

Also Published As

Publication number Publication date
JP2009539786A (ja) 2009-11-19
EP2029121A1 (de) 2009-03-04
DE102006026578B4 (de) 2009-01-08
EP2029121B1 (de) 2010-03-03
PT2029121E (pt) 2010-05-11
JP5757682B2 (ja) 2015-07-29
US20090258062A1 (en) 2009-10-15
CA2652216C (en) 2016-02-16
BRPI0712420A2 (pt) 2012-09-04
CN101466361A (zh) 2009-06-24
ATE459345T1 (de) 2010-03-15
ES2340732T3 (es) 2010-06-08
DE102006026578A1 (de) 2007-12-13
WO2007140909A1 (de) 2007-12-13
PL2029121T3 (pl) 2010-06-30
US10292942B2 (en) 2019-05-21
DE502007003020D1 (de) 2010-04-15
US10596126B2 (en) 2020-03-24
CN101466361B (zh) 2012-01-04
CA2652216A1 (en) 2007-12-13
US20190231710A1 (en) 2019-08-01

Similar Documents

Publication Publication Date Title
DK2029121T3 (da) Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel
AR097045A2 (es) Sistema terapéutico transdérmico
EP4218735A3 (en) Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
MX2015000114A (es) Composiciones farmaceuticas disuasivas de abuso de liberacion prolongada.
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
AR069552A1 (es) Formulaciones para el tratamiento de semillas y metodos de uso
CY1122771T1 (el) Φαρμακοτεχνικες μορφες παρατεταμενης αποδεσμευσης για τη χορηγηση πρωτεϊνων στον οφθαλμο και μεθοδοι για την παρασκευη αυτων
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
ECSP088560A (es) Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
EP1991277A4 (en) DELIVERY OF BIOLOGICALLY ACTIVE MATERIALS WITH CORE-SHELL TECTO (DENDRITEN POLYMERS)
MX2015008286A (es) Composiciones multipolimericas para liberación transdermica de farmaco.
WO2010100650A3 (en) Therapeutic uses of mastic gum fractions
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CY1114311T1 (el) Θεραπευτικα συστηματα αμεσης απελευθερωσης για βελτιωμενη απο του στοματος απορροφηση 7-[(ε)-τριτ-βουτυλοξυιμινομεθυλο]καμπτοθεκινης
MX2010000965A (es) Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos.
CO6382109A2 (es) Formulación de depósito de octreotida con niveles de exposición constantemente altos
WO2013013038A3 (en) Doping agents and polymeric compositions thereof for controlled drug delivery
WO2008101173A3 (en) Biodegradable compositions and materials
MX341642B (es) Composicion de liberacion sostenida que contiene peptidos como ingredientes activos.